Biostatistics Advance Access published online on January 27, 2006
Biostatistics, doi:10.1093/biostatistics/kxj020
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 USA
* To whom correspondence should be addressed. The state of readiness for high-dimensional single nucleotide polymorphism (SNP) epidemiologic association studies is described, as background for a discussion of statistical aspects of case-control study design and analysis. Specifically, the important role that multistage designs can play in the elimination of false positive associations and in the control of study costs will be noted. Also, the tradeoffs associated with using pooled DNA at early design stages for additional important cost reductions will be discussed in some detail. An odds ratio approach to relating SNP alleles to disease risk using pooled DNA will be proposed, in conjunction with a simple empirical variance estimator, based on comparisons among log-odds ratio estimators from distinct pairs of case and control pools. Simulation studies will be presented to evaluate the moderate sample size properties of such multistage designs and estimation procedures. The design of an ongoing three-stage study in the Women's Health Initiative to relate 250,000 SNPs to the risk of coronary heart disease, stroke and breast cancer will provide illustration, and will be used to motivate the choice of simulation configurations.
Received June 28, 2005
Revised January 19, 2006
Accepted January 24, 2006
Article
Aspects of the Design and Analysis of High-Dimensional SNP Studies for Disease Risk Estimation
Ross L. Prentice 1 *
and
Lihong Qi 1
Ross L. Prentice, E-mail: rprentic{at}fhcrc.org
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. L. Prentice, Y. Huang, D. A. Hinds, U. Peters, M. Pettinger, D. R. Cox, E. Beilharz, R. T. Chlebowski, J. E. Rossouw, B. Caan, et al. Variation in the FGFR2 Gene and the Effects of Postmenopausal Hormone Therapy on Invasive Breast Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 3079 - 3085. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kitamura, K. Akazawa, A. Miyashita, R. Kuwano, S.-i. Toyabe, J. Nakamura, N. Nakamura, T. Sato, and M. A. Hoque Programs for calculating the statistical powers of detecting susceptibility genes in case-control studies based on multistage designs Bioinformatics, January 15, 2009; 25(2): 272 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhong and R. L. Prentice Bias-reduced estimators and confidence intervals for odds ratios in genome-wide association studies Biostat., October 1, 2008; 9(4): 621 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Johnson Bayesian method for gene detection and mapping, using a case and control design and DNA pooling Biostat., July 1, 2007; 8(3): 546 - 565. [Abstract] [Full Text] [PDF] |
||||


